MD Medical Group expands Mother&Child Yugo-Zapad clinic in Moscow
|Download file (217 K)|
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has expanded its Mother&Child Yugo-Zapad clinic in Moscow. Total investment in the project amounted to 29.3 million roubles.
MDMG has increased the area of the clinic from 541 sq. m to 801 sq. m. As a result, four specialised offices for out-patient treatments by obstetrician-gynaecologists and other specialists, including physiсians, endocrynologists, cardiologists, physiotherapists, and vascular surgeons, were opened. The additions also include a procedure room and a surgery unit with a three-bed day-patient centre. The IVF department’s reproductive health specialist rooms were also expanded.
The upgraded clinic is capable of carrying out up to 350 minor gynaecological operations in the day-patient centre and up to 26,800 out-patient treatments in gynaecology per year.
Mark Kurtser, CEO of MD Medical Group, said:
“This significant expansion of the Mother&Child Yugo-Zapad out-patient clinic in Moscow demonstrates that our services are in high demand in the Russian capital. As is the case with our other medical facilities across the country, we are moving towards expanding our offering in OBGYN, reproductive health and fertility, as well as out-patient treatments for all family members.”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 36 modern healthcare facilities, including 5 hospitals and 31 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, and Nizhny Novgorod.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2018 2017 2016 2015 2014 2013 2012